Contact
searchSearch
HMP Global

Allergen Focus

Allergen Focus
Focus On: Allergen Exposures in Wound Care with a Highlight on Quinolines
01/09/2009
In 1997 the Food and Drug Administration approved the Thin-layer Rapid Use Epicutaneous (T.R.U.E.) Test for use as a valuable, first-line screening tool to assess for allergic contact dermatitis. Many dermatologists use this standard tool in...
In 1997 the Food and Drug Administration approved the Thin-layer Rapid Use Epicutaneous (T.R.U.E.) Test for use as a valuable, first-line screening tool to assess for allergic contact dermatitis. Many dermatologists use this standard tool in...
In 1997 the Food and Drug...
01/09/2009
The Dermatologist
Allergen Focus
Focus on the Non-T.R.U.E. Test Allergen: Sorbitans
11/10/2008
In 1997, the Food and Drug Administration gave indication to the Thin-layer Rapid Use Epicutaneous (T.R.U.E.) Test for use as a valuable, first-line screening tool in the diagnosis of allergic contact dermatitis (ACD). Many dermatologists and...
In 1997, the Food and Drug Administration gave indication to the Thin-layer Rapid Use Epicutaneous (T.R.U.E.) Test for use as a valuable, first-line screening tool in the diagnosis of allergic contact dermatitis (ACD). Many dermatologists and...
In 1997, the Food and Drug...
11/10/2008
The Dermatologist
Allergen Focus
Focus On: Bacitracin Allergen of the Year 2003
10/16/2008
In 1997, the Food and Drug Administration gave indication to the Thin-layer Rapid Use Epicutaneous (T.R.U.E.) Test for use as a valuable, first-line screening tool in the diagnosis of allergic contact dermatitis (ACD). Many dermatologists and...
In 1997, the Food and Drug Administration gave indication to the Thin-layer Rapid Use Epicutaneous (T.R.U.E.) Test for use as a valuable, first-line screening tool in the diagnosis of allergic contact dermatitis (ACD). Many dermatologists and...
In 1997, the Food and Drug...
10/16/2008
The Dermatologist
Allergen Focus
Focus On: COCAMIDE DEA (COCAMIDE DIETHANOLAMINE)
09/22/2008
In 1997 the Food and Drug Administration gave indication to the Thin-layer Rapid-Use Epicutaneous (T.R.U.E.) test for use as a “valuable,” first-line screening tool in the diagnosis of allergic contact dermatitis (ACD). Many dermatologists...
In 1997 the Food and Drug Administration gave indication to the Thin-layer Rapid-Use Epicutaneous (T.R.U.E.) test for use as a “valuable,” first-line screening tool in the diagnosis of allergic contact dermatitis (ACD). Many dermatologists...
In 1997 the Food and Drug...
09/22/2008
The Dermatologist
Allergen Focus
Focus on T.R.U.E. Test Allergen #12: Cobalt
09/04/2008
T he thin-layer rapid use epicutaneous (T.R.U.E.) test of 23 common allergens is a valuable, first-line screening tool used by many dermatologists. Although the test focuses on common allergens, frequent questions have arisen from colleagues...
T he thin-layer rapid use epicutaneous (T.R.U.E.) test of 23 common allergens is a valuable, first-line screening tool used by many dermatologists. Although the test focuses on common allergens, frequent questions have arisen from colleagues...
T he thin-layer rapid use...
09/04/2008
The Dermatologist
Allergen Focus
Focus on T.R.U.E. Test Allergen #1: Nickel
09/04/2008
T he thin-layer rapid-use epicutaneous (T.R.U.E) test of 23 common allergens is a valuable, first-line screening tool used by many dermatologists. Although the test focuses on common allergens, frequent questions have arisen from colleagues...
T he thin-layer rapid-use epicutaneous (T.R.U.E) test of 23 common allergens is a valuable, first-line screening tool used by many dermatologists. Although the test focuses on common allergens, frequent questions have arisen from colleagues...
T he thin-layer rapid-use...
09/04/2008
The Dermatologist
Allergen Focus
Focus on T.R.U.E. Test Allergen #2: Lanolin-Wool Wax
09/04/2008
T he thin-layer rapid use epicutaneous (T.R.U.E.) Test of 23 common allergens is a valuable, first-line screening tool used by many dermatologists. Although the test focuses on common allergens, frequent questions have arisen from colleagues...
T he thin-layer rapid use epicutaneous (T.R.U.E.) Test of 23 common allergens is a valuable, first-line screening tool used by many dermatologists. Although the test focuses on common allergens, frequent questions have arisen from colleagues...
T he thin-layer rapid use...
09/04/2008
The Dermatologist
Allergen Focus
Focus on T.R.U.E. Test Allergen #10: Balsam of Peru
09/04/2008
T he thin-layer rapid use epicutaneous (T.R.U.E.) Test of 23 common allergens is a valuable, first-line screening tool used by many dermatologists. Although the test focuses on common allergens, frequent questions have arisen from colleagues...
T he thin-layer rapid use epicutaneous (T.R.U.E.) Test of 23 common allergens is a valuable, first-line screening tool used by many dermatologists. Although the test focuses on common allergens, frequent questions have arisen from colleagues...
T he thin-layer rapid use...
09/04/2008
The Dermatologist
Allergen Focus
Focus on T.R.U.E. Test Allergens #21, 13 and 18: Formaldehyde and Formaldehyde-Releasing Preservatives
09/04/2008
A llergic Contact Dermatitis is an important disease with a high impact both in terms of patient morbidity and economics. The contact dermatitides include irritant contact dermatitis, contact urticaria and allergic contact dermatitis....
A llergic Contact Dermatitis is an important disease with a high impact both in terms of patient morbidity and economics. The contact dermatitides include irritant contact dermatitis, contact urticaria and allergic contact dermatitis....
A llergic Contact Dermatitis is...
09/04/2008
The Dermatologist
Allergen Focus
Focus on T.R.U.E. Test Allergens #23: Thimerosal
09/04/2008
A llergic contact dermatitis (ACD) is an important disease with high impact both in terms of patient morbidity and economics. The contact dermatitides include allergic contact dermatitis, irritant contact dermatitis and contact...
A llergic contact dermatitis (ACD) is an important disease with high impact both in terms of patient morbidity and economics. The contact dermatitides include allergic contact dermatitis, irritant contact dermatitis and contact...
A llergic contact dermatitis...
09/04/2008
The Dermatologist

Current Issue

October 2024
Volume 32
Issue 7
Current Issue
Issue Archive

Popular Articles

Practice Pearls
What You Should
Know About EMRs
09/04/2008
E lectronic medical records (EMRs). Just simply seeing this term evokes a wide range of thoughts and feelings among physicians. Many are enthusiastically jumping on the bandwagon and implementing EMRs in their practices; others are doing the...
E lectronic medical records (EMRs). Just simply seeing this term evokes a wide range of thoughts and feelings among physicians. Many are enthusiastically jumping on the bandwagon and implementing EMRs in their practices; others are doing the...
E lectronic medical records...
09/04/2008
The Dermatologist
Elisha Myers
Q&As
Cost Reduction and Health Care Barriers: Atopic Dermatitis
12/08/2022
In this feature interview, The Dermatologist met with Elisha Myers to discuss her recent study.
In this feature interview, The Dermatologist met with Elisha Myers to discuss her recent study.
In this feature interview, The...
12/08/2022
The Dermatologist
Allergen Focus
Focus on T.R.U.E. Test Allergen #3: Neomycin
09/04/2008
T he thin-layer rapid use epicutaneous (T.R.U.E) Test of 23 common allergens is a valuable, first-line screening tool used by many dermatologists. Although the test focuses on common allergens, frequent questions have arisen from colleagues...
T he thin-layer rapid use epicutaneous (T.R.U.E) Test of 23 common allergens is a valuable, first-line screening tool used by many dermatologists. Although the test focuses on common allergens, frequent questions have arisen from colleagues...
T he thin-layer rapid use...
09/04/2008
The Dermatologist
Feature Story
Breaking Down Upcoming Legislative Changes
02/06/2023
Stay up-to-date on the intersection of health care, health policy, and technology to be prepared to adapt to new rules, regulations, and care delivery models.
Stay up-to-date on the intersection of health care, health policy, and technology to be prepared to adapt to new rules, regulations, and care delivery models.
Stay up-to-date on the...
02/06/2023
The Dermatologist
Cosmetic Clinic
Isolagen:
A New Horizon?
09/04/2008
S ince 1982, when collagen was first approved for use in humans, not much has really changed in the collagen soft tissue augmentation market. The bovine collagen that was initially used was cross-linked for additional stability and the...
S ince 1982, when collagen was first approved for use in humans, not much has really changed in the collagen soft tissue augmentation market. The bovine collagen that was initially used was cross-linked for additional stability and the...
S ince 1982, when collagen was...
09/04/2008
The Dermatologist

Subscribe

The Dermatologist Newsletter

Latest Quizzes and Trivia

Atopic dermatitis
Quiz
Pediatric Atopic Dermatitis Management
11/11/2024
1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...
1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...
1. What alternative therapies...
11/11/2024
The Dermatologist
Illustration of a T cell
QUIZ
Test Your Knowledge: The Immunology of Alopecia Areata
11/04/2024
11/04/2024
The Dermatologist
psoriasis
Quiz
Long-Term Safety of Risankizumab
10/18/2024
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings...
10/18/2024
The Dermatologist
Brain
Quiz
Barriers to Mental Health Support
10/10/2024
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to...
10/10/2024
The Dermatologist
AD
Quiz
QUIZ: Psoriasis and Atopic Dermatitis: Nonsteroidal Topical Therapies
09/15/2024
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein...
09/15/2024
The Dermatologist
psoriasis
Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist
basal cell carcinoma
Quiz
True or False: Basal Cell Carcinoma on Vermilion Lip
05/01/2024
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the...
05/01/2024
The Dermatologist

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use